Genistein

Catalog No.S1342

Genistein Chemical Structure

Molecular Weight(MW): 270.24

Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 110 In stock
USD 170 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective EGFR Inhibitors

Biological Activity

Description Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.
Targets
EGFR [1] topo II [1]
In vitro

Genistein is an ATP competitive inhibitor. Genistein inhibits tyrosine phosphorylation in isolated enzyme and receptor preparations and in whole cells including platelets, lymphocytes and a variety of cultured cells. It also inhibits EGF-stimulated phosphorylation in cultured cells as well as inhibition of Topo II (topoisomerase II). Genistein inhibits EGF-stimulated tyrosine phosphorylation in cultured A431 epidermoid carcinoma cells. Inhibition is competitive with ATP and noncompetitive with substrate. [1] Genistein blocks the mitogenic effect mediated by EGF, insulin and thrombin on NIH-3T3 cells.[2] Genistein also acts as an agonist at the GPR30 receptor and binds to PPARγ and estrogen receptors. Genistein also binds to PPARγ, acting as an agonist at this receptor with Ki of 5.7 μM. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
293T cells M{fTd2Z2dmO2aX;uJIF{e2G7 NXe3dFBPTGm|cHzhZ4Vu\W62IH;mJHs{UF1zN3LleIEu\XO2cnHkbY9tKG[{b32gdoVkd22kaX7hcpQhcHWvYX6gSXJj\XSjIHX4dJJme3OnZDDpckAzQTOWIHPlcIx{NCCLQ{WwQVAvODBzMzFOwG0> NGLrdGYyPjJzOUS2Ny=>
HeLa cells M2rCS2Z2dmO2aX;uJIF{e2G7 MUTBZ5RqfmG2aX;uJI9nKGW|dILv[4VvKHKnc4DvcpNmKGWuZX3lcpQhcW5iSHXMZUBk\WyuczDzeIFjdHlidILhcpNn\WO2ZXSge4l1cCCqdX3hckBGe3S{b3flckBz\WOncITvdkBj\XSjLDDFR|UxRTBwMEC0NUDPxE1? MlTkNVE6ODZ{OEC=
human Ishikawa cells NXLwe213TnWwY4Tpc44h[XO|YYm= MmDSOEBl[Xm| NVzEZlNZTXO2cn;n[Y5q[yCjY4Tpeol1gSCrbjDoeY1idiCLc3jpb4F4[SClZXzsd{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gZYxs[WyrbnWgdIhwe3CqYYThd4Uh[WO2aY\peJkh[W[2ZYKgOEBl[Xm|IHL5JJBiemFvbnn0do9xcGWwb3ygdoVt\WG|ZTDhd5NigSxiSVO1NF0xNjVzIN88US=> M4Cwe|EzPTB{M{C3
human MCF7 cells MnHUR5l1d3SxeHnjxsBie3OjeR?= Mo\EOFghcA>? Ml\vR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUGg{txO MljQNlA5OTN3MkS=
NIH3T3 cells Mm\WSpVv[3Srb36gZZN{[Xl? M1vnemFod26rc4SgZYN1cX[rdImgZZQhS0[WUj3k[Yx1[UZ3MEigcZV1[W62IHX4dJJme3OnZDDpckBPUUh|VEOgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4h\m:{c3vvcIlvNXO2aX31cIF1\WRiY4XydoVvfCxiRVO1NF01NjRizszN MXOxPFU6PTZ7Nh?=
human HL60 cells M3fWbmZ2dmO2aX;uJIF{e2G7 M4C5NFI1KGh? NF3W[oxCdnSrbHX1b4VucWNiYXP0bZZqfHliYXfhbY5{fCCqdX3hckBJVDZyIHPlcIx{KGGodHXyJFI1KGi{czDifUBkdG:wb3flcolkKGG|c3H5MEBNSzVyPU[uN{DPxE1? MnLpNVgyPjN3OEm=
mouse L1210 cells NX\ySYU1TnWwY4Tpc44h[XO|YYm= M3HreFI1KGh? Mn7qRY51cWyndXvlcYlkKGGldHn2bZR6KGGpYXnud5QhdW:3c3WgUFEzOTBiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JINtd26xZ3XubYMh[XO|YYmsJGxEPTB;Nj61JO69VQ>? NVvFWJdQOThzNkO1PFk>
MDCK cells  NGDJZ2dHfW6ldHnvckBie3OjeR?= NVv5XZNSUW6qaXLpeIlwdiCxZjDCR3JRKGW6cILld5Nm\CCrbjDNSGNMKGOnbHzzJJV{cW6pIFjv[YNpe3RiM{OzOFIhe3SjaX7pcoctKEmFNUC9Ok46KM7:TR?= NV7WToJ2OjF|NUS4NFA>
human MOLT3 cells M3rGUWZ2dmO2aX;uJIF{e2G7 NGPnNmgzPCCq NWLhTVZRSW62aXzleYtmdWmlIHHjeIl3cXS7IHHnZYlve3RiaIXtZY4hVU:OVEOgZ4VtdHNiYX\0[ZIhOjRiaILzJIJ6KGOub37v[4VvcWNiYYPzZZktKEyFNUC9O{42KM7:TR?= NHjSfo8yQDF4M{W4PS=>
ANN-1 cells M37ibWN6fG:2b4jpZ:Kh[XO|YYm= NVXHSFFXS3m2b4TvfIlkKGWoZnXjeEBwdiC4LXHicEB1emGwc3\vdo1m\CCvdYLpcoUhSU6QLUGgZ4VtdHNuIFnDOVA:QCEQvF2= M1fy[lgzODF4MEO=
human MCF7 cells MmjpVJJwdGmoZYLheIlwdiCjc4PhfS=> NWrZO5lvSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBme3S{b3flckBz\WOncITvdkBmgHC{ZYPzbY5oKGi3bXHuJG1ETjdiY3XscJMtKEeLNUC9NVAh|ryP MYixPVgyQDZzMh?=
human Raji cells NYThRZV{TnWwY4Tpc44h[XO|YYm= NUWzcGZFOjRiaB?= NXXtN5RnSW62aXzleYtmdWmlIHHjeIl3cXS7IHHnZYlve3RiaIXtZY4hWmGsaTDj[YxteyCjZoTldkAzPCCqcoOgZpkh[2yxbn;n[Y5q[yCjc4PhfUwhVEN3ME2xN{44KM7:TR?= MX:xPFE3OzV6OR?=
human LoVo cells MWDDfZRwfG:6aXRCpIF{e2G7 MnvqO|IhcA>? M3H2PGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGxwXm9iY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2xOU45QCEQvF2= MYGyNVEzQTl5Nx?=
K562 cells NH3CbpNIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MUK1JIRigXN? NHHke|BIem:5dHigbY5pcWKrdHnvckBw\iCNNU[yJINmdGy|IHL5JHhVXCCjc4PhfUBi\nSncjC1JIRigXNuIFnDOVA:OTdwNU[g{txO NVv6cWd6OTd2MUGwPVI>
RAW 264 cells M1jsbGZ2dmO2aX;uJIF{e2G7 NFXLXJQzPCCq NInDOpFKdmirYnn0bY9vKG:oIEGgeYcwdWxiTGDTMZN1cW23bHH0[YQhXE6IYXzwbIEh[WOldX31cIF1cW:wIHnuJHJCXyB{NkSgZ4VtdHNiYX\0[ZIhOjRiaILzMEBKSzVyPUG4MlEh|ryP NV;ldoZDOTd|MkCyOFY>
mouse RAW264.7 cells MmPoSpVv[3Srb36gZZN{[Xl? NXfVdVJOOjRiaB?= MYPBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJI1wfXOnIGLBW|I3PC55IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhVFCVLXnu[JVk\WRiVF7GZYxxcGFicILv[JVkfGmxbjD0doVifGWmIEKgbJJ{KGKnZn;y[UBNWFNiY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{BjgSCHTFnTRUwhUUN3ME2xPU4yKM7:TR?= MlW3NlEzQDh5Mke=
HEK293 cells M1S4c2Z2dmO2aX;uJIF{e2G7 M3nTOWFvfGGpb37pd5Qh[WO2aY\peJkh[XRiaIXtZY4hemWlb33ibY5idnRiTGjSZoV1[SCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3ME2yNkDPxE1? MVqxPFM1OzF{Nh?=
3T3 cells NX;SblhpS3m2b4TvfIlkyqCjc4PhfS=> MX3DfZRwfG:6aXOg[YZn\WO2IH;uJFNVOyClZXzsd{whUUN3ME2yOEDPxE1? NIjz[5E5OjBzNkCz
human MCF7 cells MnPZSpVv[3Srb36gZZN{[Xl? NWnF[5VOPiCq MV;Jcohq[mm2aX;uJI9nKHCqb4Lic4wh\XO2ZYKtbY5lfWOnZDDvdo5qfGirbnWg[IVk[XKkb4j5cIF{\SCrbjDoeY1idiCPQ1[3JINmdGy|IHHmeIVzKDZiaILzMEBKSzVyPUK2JO69VQ>? MYGxNFA4PTd2Mh?=
WiDr human colon cells MW\DfZRwfG:6aXRCpIF{e2G7 MWPDfZRwfG:6aXOg[YZn\WO2IH;uJHdqTHJiaIXtZY4h[2:ub36gZ4VtdHNuIFnDOVA:OjdwNzFOwG0> MonjPFIxOTZyMx?=
NHEM cells MmTYSpVv[3Srb36gZZN{[Xl? MmXqO|IhcA>? NXn1VGN3UW6qaXLpeIlwdiCxZjDt[YxidmmwIIP5cpRp\XOrczDpckBPUEWPIHPlcIx{KGG|c3Xzd4VlKGG|IGuxOGNefGirb4XyZYNqdCCrbnPvdpBwemG2aX;uJIFnfGW{IEeyJIhzeyCkeTDsbZF2cWRic3PpcpRqdGyjdHnvckBkd3WwdHnu[{whUUN3ME2yPU4zKM7:TR?= M4izUFE6OTN{OUO0
human BxPC3 cell M2jtVXBzd2yrZnXyZZRqd25iYYPzZZk> MWTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEK6UFOzJINmdGxibHnu[UBjgSCPVGSgZZN{[XluIFnDOVA:OzBizszN MkjDNVY4QDl5M{e=
human LNCAP cells MWTDfZRwfG:6aXRCpIF{e2G7 NHvSUWE4OiCq MXLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMUmNCWCClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUOwMlY2KM7:TR?= MnfONlEyOjl7N{e=
HEK293 cells M16zTmZ2dmO2aX;uJIF{e2G7 NXfLclBKSW62YXfvcol{fCCjY4Tpeol1gSCjdDDoeY1idiC{ZXPvcYJqdmGwdDDMXHJidHCqYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiSVO1NF0{OSEQvF2= MXqxPFM1OzF{Nh?=
human HCT116 cells M{DoRWN6fG:2b4jpZ:Kh[XO|YYm= NHjJSXo4OiCq MX\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME2zOE46KM7:TR?= NEXKOJYzOTF{OUm3Oy=>
human AGS cells MlLFR5l1d3SxeHnjxsBie3OjeR?= MX:3NkBp NFm0[ndEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCT1NiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3ME20NU43PyEQvF2= M4GwflIyOTJ7OUe3
human PC3 cells MUDQdo9tcW[ncnH0bY9vKGG|c3H5 MlnmOFghcA>? NVzKRZAySW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBidmS{b3flckBz\WOncITvdk1l\W[rY3nlcpQhcHWvYX6gVGM{KGOnbHzzJIlv[3WkYYTl[EB4cXSqIECuOkBvVSCxZjDld5Rz[WSrb3ygZY5lKDBwNzDuUUBw\iC2ZYP0c5N1\XKxbnWgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9OFIvPjV6IN88US=> MkOxNlE2OTN{N{W=
human A549 cells MUHDfZRwfG:6aXRCpIF{e2G7 M2LR[|czKGh? MX3DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDTVmIh[XO|YYmsJGlEPTB;NEOuNFkh|ryP M2e1eVIyOTJ7OUe3
human BT20 cell NWrQfmd4WHKxbHnm[ZJifGmxbjDhd5NigQ>? NILnb4VCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFLUNlAh[2WubDDsbY5mKGK7IF3UWEBie3OjeTygTWM2OD12NjFOwG0> MkjwNVY4QDl5M{e=
human DU145 cells M3LQVmN6fG:2b4jpZ:Kh[XO|YYm= MY[3NkBp MVTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUS3MlI6KM7:TR?= NX7tW2lOOjFzMkm5O|c>
human U937 cells NVv3Olk3WHKxbHnm[ZJifGmxbjDhd5NigQ>? MWq3NkBp M4PSZWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVUmzO{Bk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUMVgh[XO|YYmsJGlEPTB;NEig{txO NWDoeWF{OTdzNUiwOVQ>
human MOLT3 cells M3r0Vmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NWTJcWNqPDhiaB?= M3u5S2dzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJG1QVFR|IHPlcIx{KGGodHXyJFQ5KGi{cx?= NXL3NHVKOThzNkO1PFk>
human T47D cells MljKSpVv[3Srb36gZZN{[Xl? MVPFd5Rzd2enbnnjJIFkfGm4aYT5JIlvKGi3bXHuJHQ1P0RiY3XscJMh[XO|ZYPz[YQh[XNiZIL1[{Bt\X[nbDDjZZV{cW6pIIP0bY12dGG2aX;uJI9nKGOnbHygdJJwdGmoZYLheIlwdiCncYXpeoFt\W62IITvJFExKHCPIHXzeJJi\GmxbDDifUBidGGvYYKgZox2\SCjc4PhfS=> MUCxOVc5PzR|Nh?=
human MDA-kb2 cells MXzGeY5kfGmxbjDhd5NigQ>? MVrB[49vcXO2IHHjeIl3cXS7IHH0JIFv\HKxZ3XuJJJm[2WydH;yJIlvKGi3bXHuJG1FSS2tYkKgZ4VtdHNiYYPz[ZN{\WRiYYOgd5RqdXWuYYTpc44hd2ZibIXjbYZmemG|ZTDhZ5Rqfmm2eTDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? MXexPVU6OjJ2NR?=
human MCF7 cells Moe0SpVv[3Srb36gZZN{[Xl? NH[0cGQxNjFvMkCg{txO MXK0JIRigXN? NGP5bYpUfGmvdXzheIlwdiCxZjDndo94fGhiaX6gbJVu[W5iTVPGO{Bk\WyuczDheEAxNjFidH:gNlAhfU1iYX\0[ZIhPCCmYYnzJIJ6KE2WVDDhd5NigQ>? M4[zNFI2ODd6M{G0
HUVE12 cells NFTCSHZHfW6ldHnvckBie3OjeR?= MWTS[ZZmenOjbDDv[kBpgWS{b3flckBx\XKxeHnk[U1qdmS3Y3XkJGxFUCCjY4Tpeol1gSCrbjDoeY1idiCKVW\FNVIh[2WubIO= MUKxPFA3QDl6MB?=
human MCF7 cells NIj1eFJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NF7MRVAzOC1zMECg{txO NVvwS4RVPCCmYYnz M2fv[Wdzd3e2aDDpcohq[mm2aX;uJIlvKGi3bXHuJG1ETjdiY3XscJMh[XRiMkCgeI8hOTByIIXNJIFnfGW{IESg[IF6eyCkeTDNWHQh[XO|YYm= M{\jPFI2ODd6M{G0
A431 cells NY\VWWhKTnWwY4Tpc44h[XO|YYm= NGmyUmQ2OCC2bzC3OUB2VQ>? M{HKc|M3KGh? MVvD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDBOFMyKGOnbHzzJIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIHHjZ5VufWyjdHnvckBifCCJMD;HNUBxcGG|ZTDheEA2OCC2bzC3OUB2VSCjZoTldkA{PiCqcoOgZpkheHKxcHnkbZVuKGmxZHnk[UB{fGGrbnnu[{1j[XOnZDDmcI94KGO7dH;t[ZRzcWNiYX7hcJl{cXN? NG\x[JYzPDR3NkCwOC=>
human SKBR3 cells M2DPR2Z2dmO2aX;uJIF{e2G7 MXW1NEB1dyB5NTD1US=> M4nHOVM3KGh? MXTD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDTT2JTOyClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDhZ4N2dXWuYYTpc44h[XRiR{CvS|EheGijc3WgZZQhPTBidH:gO|UhfU1iYX\0[ZIhOzZiaILzJIJ6KHC{b4Dp[Il2dSCrb3Tp[IUhe3SjaX7pcocu[mG|ZXSg[oxwfyCleYTvcYV1emmlIHHuZYx6e2m| NVfnNW1NOjR2NU[wNFQ>

... Click to View More Cell Line Experimental Data

In vivo Genistein has chemopreventive effects on breast, prostate, and other endocrine-dependent tumors in adult animals. Genistein in the diet reduced the incidence of poorly differentiated prostatic adenocarcinomas in a dose-dependent manner and down-regulated androgen receptor, estrogen receptor-alpha, progesterone receptor, epidermal growth factor receptor, insulin-like growth factor-I, and extracellular signal-regulated kinase-1 but not estrogen receptor-beta and transforming growth factor-alpha mRNA expressions. Dietary genistein protects against mammary and prostate cancers by regulating specific sex steroid receptors and growth factor signaling pathways.[4] Genistein combined with prostate tumor irradiation causes greater inhibition of primary tumor growth and increases control of spontaneous metastasis to para-aortic lymph nodes, increasing mouse survival. Paradoxically, treatment with genistein alone increases metastasis to lymph nodes. [5]

Protocol

Solubility (25°C)

In vitro DMSO 54 mg/mL (199.82 mM)
Ethanol 2 mg/mL (7.4 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 270.24
Formula

C15H10O5

CAS No. 446-72-0
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01982578 Recruiting Dietary Supplement: Genistein|Other: Placebo Alzheimer''s Disease Fundación para la Investigación del Hospital Clínico de Valencia|University of Valencia September 1 2017 Not Applicable
NCT02499861 Completed Drug: Decitabine and Genistein Cancer St. Justine''s Hospital July 2015 Phase 1|Phase 2
NCT01628471 Completed Drug: decitabine in combination with genistein Non Small Cell Lung Cancer Uman Pharma|DSM Nutritional Products Inc.|MDEIE Ministry Québec Government|INRS-Institut Armand Frappier Université du Québec November 2012 Phase 1|Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

EGFR Signaling Pathway Map

Related EGFR Products

Tags: buy Genistein | Genistein supplier | purchase Genistein | Genistein cost | Genistein manufacturer | order Genistein | Genistein distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID